A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party

(2010) A. Bacigalupo et al.   HAEMATOLOGICA

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

(2009) R. A. Brodsky et al.   BLOOD

Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA

(2009) Antonio Maria Risitano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study

(2009) P. Scheinberg et al.   HAEMATOLOGICA

Hematopoietic growth factors in aplastic anemia patients treated with immunosuppressive therapy-systematic review and meta-analysis

(2009) R. Gurion et al.   HAEMATOLOGICA

Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia

(2008) Phillip Scheinberg et al.   BRITISH JOURNAL OF HAEMATOLOGY